The Company

co.don^® AG has developed therapy concepts , wich are using the "power" of  own cells to rebuild and improve live quality of the patients.

We are a biopharmaceutical company seeking to advance medical treatment with innovative options. With an internal research and development department, and an external network of partners, a promising product pipeline seems guaranteed.

Completely new products will be realized with the advent of Tissue Engineering, a technology that offers the opportunity to cultivate cells and tissues.

An interdisciplinary team has been assembled with diverse and separate expertise in biology, biochemistry, biophysics, biotechnology, medicine and pharmaceutics to develop the new platform technology.

This forms the basis for the economical and individual - for each patient - manufacturing of quality, cell-based and biological therapeutics.

High qualified surgeons assure the highest level of pharmaceutical an patient safety. A dense, growing network of distributors in Germany and Europe provide a wide market penetration.

With an accent on products and service, co.don^® accepts the challenge of restoring an improved quality of life to the people it serves.